COMMUNIQUÉS West-GlobeNewswire

-
Roche’s Evrysdi tablet approved by European Commission as first and only for Spinal Muscular Atrophy (SMA)
04/06/2025 -
Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Corporate Update
04/06/2025 -
Valneva annonce la mise à disposition des documents préparatoires à son Assemblée Générale Mixte et une évolution de son équipe de direction
04/06/2025 -
World's Leading Institutions and IBA launch Proton Therapy Academy to shape the future of cancer care
04/06/2025 -
Des institutions mondiales de renom et IBA lancent la Proton Therapy Academy pour élaborer l'avenir des soins contre le cancer
04/06/2025 -
Merus N.V. Announces Pricing of Public Offering of Common Shares
04/06/2025 -
More Than a Symposium: IOF Builds Momentum Toward the Future of Orthodontics
04/06/2025 -
AVITA Medical’s RECELL Platform Recognized for Surgical Innovation in 2025 MedTech Breakthrough Awards
04/06/2025 -
Teva Announces Pricing and Early Acceptance Results of its Debt Tender Offer
03/06/2025 -
Taysha Gene Therapies Announces Details for Oral Presentations at the 2025 IRSF Rett Syndrome Scientific Meeting Reviewing Recent Updates from the TSHA-102 Clinical Program
03/06/2025 -
Ultragenyx to Participate at Goldman Sachs 46th Annual Global Healthcare Conference
03/06/2025 -
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
03/06/2025 -
Fennec Announces Results of Annual Meeting
03/06/2025 -
Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08
03/06/2025 -
DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document
03/06/2025 -
DBV Technologies publie un amendement à son Document d’enregistrement universel 2024
03/06/2025 -
U.S. FDA approves third indication of darolutamide for patients with advanced prostate cancer
03/06/2025 -
MacroGenics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025
03/06/2025 -
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/06/2025
Pages